scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0167-5273(02)00480-1 |
P698 | PubMed publication ID | 12767554 |
P2093 | author name string | Thomas K Makris | |
Antonios N Hatzizacharias | |||
Panagiota G Krespi | |||
Caterina G Tsoukala | |||
Emmanuel V Chronakis | |||
John S Vythoulkas | |||
Kouli Maria | |||
Vassilios V Votteas | |||
P2860 | cites work | Weight-reducing effects of the plasma protein encoded by the obese gene | Q29617934 |
Plasminogen activator inhibitor in the blood of patients with coronary artery disease | Q34490676 | ||
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis | Q37374639 | ||
High plasma immunoreactive leptin level in essential hypertension | Q38341667 | ||
Serum leptin levels are independently correlated with two measures of HDL. | Q38344105 | ||
Role of the contact system in fibrinolysis | Q39594111 | ||
Family history of coronary heart disease: is it an independent risk factor? | Q39738095 | ||
Structural changes accompanying enzymatic activation of human Hageman factor | Q40368436 | ||
Immune and inflammatory mechanisms in the development of atherosclerosis | Q40872807 | ||
Coagulation and fibrinolytic factors in normotensive hypertension-prone men. | Q40940610 | ||
Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease | Q41673431 | ||
Hyperleptinaemia: the missing link in the, metabolic syndrome? | Q50964327 | ||
Relation of risk factor levels in young adulthood to parental history of disease. The CARDIA study. | Q51609375 | ||
Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients | Q68826686 | ||
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease | Q69187061 | ||
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
A need for standardization of the anti-endothelial-cell antibody test | Q71711323 | ||
Genetic susceptibility to death from coronary heart disease in a study of twins | Q72290929 | ||
Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 | ||
Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension | Q73128347 | ||
Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis | Q77697679 | ||
Genetic epidemiology | Q93853519 | ||
P433 | issue | 2-3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 287-293 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | International Journal of Cardiology | Q2357863 |
P1476 | title | Markers of risk in young offspring with paternal history of myocardial infarction | |
P478 | volume | 89 |
Q36649341 | Better prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin |
Q37198354 | Leptin and cardiovascular disease: response to therapeutic interventions |
Q36903856 | Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction |
Q79822450 | One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents |
Search more.